Published

The safety and efficacy of COMP360 psilocybin therapy in treatment-resistant depression: results from a long-term observational follow-up study

No abstract is available for this record.

Open source BibTeX RIS

Bibliographic context

Journal: Neuroscience Applied
Date: 2022-12-31
Source: OpenAlex
DOI: 10.1016/j.nsa.2023.102906
PubMed: Unavailable

Authors

Guy M. Goodwin Lindsey Marwood S. Mistry Anna Nowakowska Zainib Shabir H. Clifton Simmons E.K. Teoh Jeng-Yu Tsai E. Malievskaia

Watch author

Citation graph

0 referenced DOIs found in stored source metadata. 1 indexed paper cite this DOI.

Open citation network

Indexed papers citing this DOI

The safety and efficacy of COMP360 psilocybin therapy in treatment-resistant depression: results from a long-term observational follow-up study2022-12-31

Related papers

The efficacy and safety of psilocybin-assisted therapy for major depressive disorder: a meta-analytic review of clinical outcomesMental Wellness · 2026-04-20 Social acceptability of psilocybin-assisted therapy for existential distress at the end of life: A population-based surveyPalliative Medicine · 2024-01-21 Psychedelic Treatment with Psilocybin: Addressing Medical Malpractice Risk and Physicians’ ConcernsThe Journal of Law Medicine & Ethics · 2024-12-31 Observational Pilot Study to Explore the Social and Health Impacts of a New Model of Care in Oregon: Psilocybin Services on AlcoholismClinicalTrials.gov · 2025-09-23 Potential use of psilocybin drugs in the treatment of depression.Unknown journal · 2023-12-25 A Working Paper: Memo on the Religious Implications of the Consciousness-Changing Drugs (LSD, Mescalin, Psilocybin)Journal for the Scientific Study of Religion · 1963-12-31 Safety and Efficacy of Psilocybin in the Management of Treatment-Resistant Depression: A Systematic ReviewResearch Square · 2026-05-10 Real-World Psilocybin Therapy for Treatment-Resistant Depression: a Retrospective Observational StudyResearch Square · 2025-12-09